ZA892104B - Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours,preparation,production and uses thereof - Google Patents

Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours,preparation,production and uses thereof

Info

Publication number
ZA892104B
ZA892104B ZA892104A ZA892104A ZA892104B ZA 892104 B ZA892104 B ZA 892104B ZA 892104 A ZA892104 A ZA 892104A ZA 892104 A ZA892104 A ZA 892104A ZA 892104 B ZA892104 B ZA 892104B
Authority
ZA
South Africa
Prior art keywords
preparation
production
active material
biologically active
generally associated
Prior art date
Application number
ZA892104A
Other languages
English (en)
Inventor
Michael John Tisdale
John Tisdale Michael
Susan Anne Beck
Anne Beck Susan
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of ZA892104B publication Critical patent/ZA892104B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
ZA892104A 1988-03-18 1989-03-20 Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours,preparation,production and uses thereof ZA892104B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888806471A GB8806471D0 (en) 1988-03-18 1988-03-18 Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours

Publications (1)

Publication Number Publication Date
ZA892104B true ZA892104B (en) 1990-05-30

Family

ID=10633675

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892104A ZA892104B (en) 1988-03-18 1989-03-20 Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours,preparation,production and uses thereof

Country Status (9)

Country Link
US (2) US5219579A (de)
EP (1) EP0335550A1 (de)
JP (1) JPH05504543A (de)
AU (1) AU637046B2 (de)
DK (1) DK222790A (de)
GB (2) GB8806471D0 (de)
IE (1) IE890873L (de)
WO (1) WO1989008709A1 (de)
ZA (1) ZA892104B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
US5552442A (en) * 1987-09-15 1996-09-03 The Rowett Research Institute Therapeutic applications of clenbuterol
DE3855801T2 (de) * 1987-09-15 1997-07-03 Rowett Research Inst Anwendungsgebiete von beta-adrenergenen Agonisten
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
GB8906369D0 (en) * 1989-03-20 1989-05-04 Tisdale Michael J Eicosapentaenoic acid
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
AU4199597A (en) * 1996-09-09 1998-04-02 Novo Nordisk A/S A cdna and peptide with relation to cancer and weight loss
JPH11269079A (ja) * 1998-03-17 1999-10-05 Shiseido Co Ltd 脂質分解促進用皮膚外用剤
US6354297B1 (en) * 1998-04-16 2002-03-12 The Uniformed Services University Of The Health Sciences Method and device for destroying fat cells by induction of programmed cell death
GB9811465D0 (en) * 1998-05-29 1998-07-29 Tisdale Michael J Glycoproteins having lipid mobilising properties and therapeutic applications thereof
US20020022036A1 (en) * 2000-08-21 2002-02-21 Riordan Neil H. Method for inducing an anti-tumor and anti-cachexia immune response in mammals
US6852693B2 (en) 2002-02-07 2005-02-08 Blm Group Compositions and methods for promoting lipid mobilization in humans
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
BRPI0407506A (pt) * 2003-02-13 2006-02-14 Wellstat Therapeutics Corp compostos para o tratamento de distúrbios metabólicos, seu uso e composição farmacêutica compreendendo os mesmos
DK1633340T3 (da) * 2003-04-15 2011-02-07 Wellstat Therapeutics Corp Forbindelser til behandling af stofskifteforstyrrelser
US7184267B2 (en) * 2003-12-12 2007-02-27 Hewlett-Packard Development Company, Lp. Longitudinally cooled electronic assembly
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism
US7361081B2 (en) * 2004-07-23 2008-04-22 Hewlett-Packard Development Company, L.P. Small form factor air jet cooling system
EP3633381A3 (de) 2013-12-05 2020-07-29 The Broad Institute, Inc. Zusammensetzungen und verfahren zur identifikation und behandlung von kachexie oder präkachexie
US11111296B2 (en) 2015-12-14 2021-09-07 The Broad Institute, Inc. Compositions and methods for treating cardiac dysfunction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0212489B1 (de) * 1985-08-16 1994-11-30 The Rockefeller University Modulator der anabolischen Aktivität und seine Verwendungen

Also Published As

Publication number Publication date
DK222790D0 (da) 1990-09-17
AU3426389A (en) 1989-10-05
AU637046B2 (en) 1993-05-20
DK222790A (da) 1990-09-17
GB8906371D0 (en) 1989-05-04
GB8806471D0 (en) 1988-04-20
EP0335550A1 (de) 1989-10-04
GB2217330B (en) 1992-08-26
GB2217330A (en) 1989-10-25
JPH05504543A (ja) 1993-07-15
US5385740A (en) 1995-01-31
US5219579A (en) 1993-06-15
IE890873L (en) 1989-09-18
WO1989008709A1 (en) 1989-09-21

Similar Documents

Publication Publication Date Title
ZA892104B (en) Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours,preparation,production and uses thereof
EP0263184A4 (de) Immobilisiertes, physiologisch aktives material.
IL74305A0 (en) N-aryl-3-aryl-4,5-dihydro-1 h-pyrazole-1-carboxamides,their production and their use as insecticides
IL83338A0 (en) 3-aryluracils,their manufacture and their use for controlling weeds
IL82507A0 (en) 1-aralkylpyrazoles,their preparation and their use as pesticides
YU12590A (en) Microcapsulated farming active material
EP0228448A4 (de) Verwendung biologisch aktiver Copolymere zur Herstellung eines Arzneimittels zur Stimulierung des Wachstums von Tieren.
IL80991A0 (en) 5-heterocyclyl-1-aryl-pyrazoles,their preparation and their use as pesticides
DE3569208D1 (en) Shaped catalysts, their preparation and use
IL81895A0 (en) N-pyridyloxyphenyl-isothioureas,their preparation and their use in pest control
IL77106A0 (en) Homopropargylamines,their preparation and their use as fungicides
IL78282A0 (en) Benzamides,their production and their use as pesticides
ZA854334B (en) Novel lactones,process for their preparation and the use thereof in pest control
IL78283A0 (en) Benzoylureas,their production and their use as pesticides
IL88393A0 (en) Imidiates,their preparation and their use as insecticides
IL89237A0 (en) Azolylmethyloxiranes,their preparation and their use as fungicides
DE3561722D1 (en) Halovinylbenzyl esters, their preparation and use as pesticides
EP0445304A4 (en) Isolated, physiologically active human thrombomodulin polypeptide
IL82019A0 (en) Acyloxythiophene-carbox-amides,their preparation and their use as pesticides
EG18799A (en) Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests
IL85993A0 (en) 1-aralkylpyrazoles,their preparation and their use as pesticides
IL77005A0 (en) Triazolylmethylcarbinol-arylacetals,their preparation and their use as fungicides
HUT48868A (en) Fungicides comprising n,n'-diacylaminals and process for producing the active ingredients
ZA875993B (en) Heteroarylethylamines,processes for the preparation thereof,and the use thereof as production promotors in livestock
GB8806472D0 (en) Biologically active material generally associated with cachexia inducing tumours